Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAPAGLIFLOZIN PROPANEDIOL\METFORMIN for Type 2 diabetes mellitus: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 831 adverse event reports in the FDA FAERS database where DAPAGLIFLOZIN PROPANEDIOL\METFORMIN was used for Type 2 diabetes mellitus.

Most Reported Side Effects for DAPAGLIFLOZIN PROPANEDIOL\METFORMIN

Side Effect Reports % Deaths Hosp.
Diabetic ketoacidosis 176 7.9% 2 125
Blood glucose increased 143 6.4% 1 31
Nausea 124 5.6% 0 51
Weight decreased 122 5.5% 3 22
Death 110 4.9% 110 10
Off label use 110 4.9% 3 28
Diarrhoea 103 4.6% 1 37
Ketoacidosis 96 4.3% 2 61
Vomiting 92 4.1% 4 49
Acute kidney injury 91 4.1% 4 75
Fatigue 77 3.4% 0 14
Metabolic acidosis 73 3.3% 5 63
Drug ineffective 72 3.2% 0 11
Dizziness 67 3.0% 0 11
Glycosylated haemoglobin increased 67 3.0% 0 9

Other Indications for DAPAGLIFLOZIN PROPANEDIOL\METFORMIN

Diabetes mellitus (509) Product used for unknown indication (99) Glucose tolerance impaired (18) Type 1 diabetes mellitus (17) Blood glucose abnormal (15) Blood glucose increased (15) Glycosylated haemoglobin increased (11) Weight decreased (11) Insulin-requiring type 2 diabetes mellitus (9) Diabetes mellitus inadequate control (8)

Other Drugs Used for Type 2 diabetes mellitus

INSULIN GLARGINE (41,731) METFORMIN (25,080) DULAGLUTIDE (24,742) SEMAGLUTIDE (17,910) INSULIN LISPRO (16,871) EXENATIDE (16,403) TIRZEPATIDE (14,571) EMPAGLIFLOZIN (12,176) CANAGLIFLOZIN (10,795) PIOGLITAZONE (8,418)

Related Pages

DAPAGLIFLOZIN PROPANEDIOL\METFORMIN Full Profile All Type 2 diabetes mellitus Drugs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN Demographics DAPAGLIFLOZIN PROPANEDIOL\METFORMIN Timeline